The deadly H5N1 bird flu outbreak in Australia has raised urgent questions about the protection of our wildlife. With over 100 wild seabirds affected and the first mass bird deaths confirmed, the time to act is now.
This highly contagious virus has already devastated seal and sea lion populations in South America and the Southern Ocean, with thousands of deaths reported. The question is not whether this virus can harm our unique wildlife, but what steps we can take to prevent a potential local extinction.
The Case for Vaccination
Vaccination, while not a complete solution, can be a powerful tool in our conservation efforts. It can prevent an outbreak from wiping out entire species in a specific area, offering a glimmer of hope for threatened birds and marine mammals.
Australia has taken some initial steps with a national policy allowing emergency vaccination of rare and protected birds. The government has also purchased an inactivated H5 vaccine and is conducting pilot studies. However, these measures are not enough, and we must learn from the proactive approach taken by countries like New Zealand, which has vaccinated its rarest birds before the virus's arrival.
A Policy Gap and a Call to Action
One critical gap in Australia's policy is the exclusion of non-avian species, particularly marine mammals. Despite their known vulnerability to H5N1, no plans have been announced for vaccination trials for seals or sea lions. This is a significant oversight, given the devastating impact the virus has had on these populations elsewhere.
International programs offer valuable insights. New Zealand, for instance, has vaccinated core breeding birds of rare species, including the iconic kākāpō and takahē. The United States, after losing 21 critically endangered California condors to H5N1, has vaccinated over 200 captive and free-flying condors. These efforts demonstrate the potential of vaccination to reduce severe disease and mortality in threatened populations.
Identifying Priority Species
Broad-scale vaccination of free-ranging wildlife is impractical, but targeted approaches can be effective. The best candidates are small, accessible populations of at-risk species, such as birds in zoos or breeding centers, or small, known colonies with regular handling.
Australia's list of at-risk species is concerning, with five bird species and several marine mammal species facing extreme or very high risks. The Christmas Island frigate bird, Houtman albatross, and imperial shags on Heard and Macquarie Islands are among the most vulnerable. On land, the Tasmanian devil and eastern quoll are at high risk.
The Urgent Need for a Seal and Sea Lion Strategy
H5N1 has had a catastrophic impact on seal and sea lion populations, with over 17,000 southern elephant seal pups killed in Argentina in 2023 and an estimated 13,359 pups dying at Australia's Heard Island in 2025. This has led to the listing of southern elephant seals as vulnerable on the IUCN Red List.
Australia's most vulnerable seals include the endangered Australian sea lion, fur seals, and southern elephant seals. With H5N1-positive terns found at Seal Bay on Kangaroo Island, home to a major sea lion breeding colony, the need for action is clear.
While there is no bird flu vaccine specifically designed for marine mammals, a US trial using a cattle vaccine on northern elephant seals showed promise, producing measurable antibodies. Conservation programs often adapt vaccines approved for domestic animals, and this approach could be crucial for Australia's seal and sea lion populations.
The Time to Act is Now
Australia must identify priority seal colonies, trial candidate vaccines, and plan vaccination deployment. We cannot afford to wait and witness more mass deaths. Vaccination is not a perfect solution, but when faced with the potential loss of years of conservation work, we must act decisively. The time to protect our unique wildlife is now, before it's too late.
